Open official notice

Zenith Alpha Thoracic Endovascular Graft The Zenith Alpha Thoracic Endovascular Graft is indicated for the endovascular treatment of

Official notice

16 Aug 2017

RecallScope risk estimate:CriticalFDA

An official FDA notice concerns Zenith Alpha Thoracic Endovascular Graft The Zenith Alpha Thoracic Endovascular Graft is indicated for the endovascular treatment of. There have been five reports of graft thrombosis/occlusion during global commercial use, each following treatment for BTAI. One case resulted in patient death, and three cases resulted in reintervention. Published 2017-08-16.

What to do now

This recall has been terminated. See the official FDA notice for the latest status.

Units affected

4,916

Recall number

Z-2099-2017

Official notice

2017-08-16

The hazard

There have been five reports of graft thrombosis/occlusion during global commercial use, each following treatment for BTAI. One case resulted in patient death, and three cases resulted in reintervention.

How to check if you’re affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Event Ids

77099

Recall Numbers

Z-2099-2017

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

Zenith Alpha Thoracic Endovascular Graft The Zenith Alpha" Thoracic Endovascular Graft is indicated for the endovascular treatment of patients with isolated lesions of the descending thoracic aorta (not including dissections) having vascular anatomy suitable for endovascular repair including: " Iliac/femoral anatomy that is suitable for access with the required introduction systems, " Nonaneurysmal aortic segments (fixation sites) proximal and distal to the thoracic lesion: " with a length of at least 20 mm, and " with a diameter measured outer wall to outer wall of no greater than 42 mm and no less than 15 mm.

Units affected

4,916

Hazard

There have been five reports of graft thrombosis/occlusion during global commercial use, each following treatment for BTAI. One case resulted in patient death, and three cases resulted in reintervention.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

US · United States

Affected area 1

US · United States

Company & contacts

Manufacturer

Cook Medical Incorporated

Phone

Not provided

Brand: Cook Medical. Contact: Cook Medical Incorporated.

Source & status

Source

Tier

official

Category

Tech & Electronics

Official classification

Class I

Recall details

Recall number

Z-2099-2017

Event ID

77099

Units affected

4,916

Status

terminated

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week’s recalls before you need them.

One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 16 Aug 2017. The next one won’t wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button